Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: August 2014
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Unimed Pharmaceuticals LLC et al. v. Perrigo Co. et al.1:14-cv-01004; filed July 31, 2014 in the District Court of Delaware • Plaintiffs: Unimed Pharmaceuticals LLC; Besins Healthcare Luxemborg SARL• Defendants: Perrigo Co.; Perrigo Israel…
-
August 18-19, 2014 - Advanced Patent Prosecution Workshop 2014: Claim Drafting & Amendment Writing (Practising Law Institute) – San Francisco, CA August 18-20, 2014 – Advanced Patent Law Seminars (Chisum Patent Academy) - Seattle, WA August 19, 2014 – "Alice Corp. v. CLS Bank International: General Purpose Computers Cannot Save Inventions Directed to Abstract Ideas" (McDonnell Boehnen Hulbert…
-
DuPont and the Widener University School of Law will be holding the 2014 Intellectual Property Continuing Legal Education Seminar on September 30, 2014 at The DuPont Country Club in Wilmington, Delaware. Among the presentations being offered at the seminar will be: • IP Due Diligence – Global Aspects / Pitfalls to Avoid• Non-Practicing Entities: Promoting…
-
Strafford will be offering a webinar/teleconference entitled "Post-AIA Section 102 and Prior Art: Navigating the Expanded Scope of Prior Art and AIA Exceptions" on September 11, 2014 from 1:00 to 2:30 pm (EDT). Thomas L. Irving of Finnegan Henderson Farabow Garrett & Dunner, Washington; John J. Cheek, Senior Corporate Counsel, Caterpillar; and John Mulcahy of…
-
Strafford will be offering a webinar/teleconference entitled "Section 103 and Obviousness: Capitalizing on CCPA and Early Federal Circuit Precedent — Strategies for Withstanding Obviousness Rejections and Attacks on Patent Validity and Patentability" on September 16, 2014 from 1:00 to 2:30 pm (EDT). Thomas L. Irving; Jill K. MacAlpine, Ph.D.; Mary Henninger, Ph.D.; and Deborah M.…
-
By Andrew Williams — Can filing a lawsuit under the Hatch-Waxman scheme of 35 U.S.C. § 271(e)(2)(A) ever give rise to antitrust liability? The Federal Circuit last week indicated in the affirmative. That statute provides that: It shall be an act of infringement to submit— (A) an application under section 505(j) of the Federal Food, Drug,…
-
By Kevin E. Noonan — On August 5th, the U.S. Food and Drug Administration issued a "Guidance for Industry" entitled "Reference Product Exclusivity for Biological Products file under Section 351(a) of the PHS Act." Before setting forth the first word of the Guidance, the Administration set forth the following caveat: This draft guidance, when finalized,…
-
By Ralph Cox* and Simon Spink** — Overview For the best part of 10 years, since the judgment of Lord Hoffmann in Kirin-Amgen v Hoescht Marion Roussel[1], it has been widely assumed that there is no file wrapper estoppel in the UK and no doctrine of equivalents either. Both these assumptions are thrown into doubt…
-
By Donald Zuhn — On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" (or "Myriad-Mayo Guidance"), to implement a new procedure for determining the subject matter eligibility of claims under 35…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Glycobiosciences Inc. v. Dara Biosciences, Inc. et al.1:14-cv-01281; filed July 28, 2014 in the District Court of the District of Columbia • Plaintiff: Glycobiosciences Inc.• Defendants: Dara Biosciences, Inc.; Helsinn Healthcare SA Infringement of…
Patent Docs 